Related references
Note: Only part of the references are listed.Patients with Rare Cancers in the Drug Rediscovery Protocol (DRUP) Benefit from Genomics-Guided Treatment
Louisa R. Hoes et al.
CLINICAL CANCER RESEARCH (2022)
Impact of tissue-agnostic approvals for patients with sarcoma
Roberto Carmagnani Pestana et al.
TRENDS IN CANCER (2022)
The 2020 WHO Classification What's New in Soft Tissue Tumor Pathology?
Michael E. Kallen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)
Analysis in the Prospective Lynch Syndrome Database identifies sarcoma as part of the Lynch syndrome tumor spectrum
Mev Dominguez-Valentin et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Driver mutations occur frequently in metastases of well-differentiated small intestine neuroendocrine tumours
Kris G. Samsom et al.
HISTOPATHOLOGY (2021)
Updates from the 2020 World Health Organization Classification of Soft Tissue and Bone Tumours
William J. Anderson et al.
HISTOPATHOLOGY (2021)
Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE
Patrick Schoffski et al.
EUROPEAN JOURNAL OF CANCER (2021)
Ewing's Sarcoma
Nicolo Riggi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Assessment of tumour-agnostic therapies in basket trials
Sanjay Popat et al.
LANCET ONCOLOGY (2021)
New Horizons in the Treatment of Osteosarcoma
Paul S. Meltzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network
Gonzague de Pinieux et al.
PLOS ONE (2021)
Relationships between highly recurrent tumor suppressor alterations in 489 leiomyosarcomas
Inga-Marie Schaefer et al.
CANCER (2021)
New treatments in advanced gastrointestinal stromal tumor
Cesar Serrano
CURRENT OPINION IN ONCOLOGY (2021)
Genomic and transcriptomic characterization of desmoplastic small round cell tumors
Saskia Sydow et al.
GENES CHROMOSOMES & CANCER (2021)
Rationale and design of the CRAFT (Continuous ReAssessment with Flexible ExTension in Rare Malignancies) multicenter phase II trial
C. E. Heilig et al.
ESMO OPEN (2021)
Integrated mutational landscape analysis of uterine leiomyosarcomas
Jungmin Choi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Gastrointestinal stromal tumours
Jean-Yves Blay et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Ewing Sarcoma-Diagnosis, Treatment, Clinical Challenges and Future Perspectives
Stefan K. Zoellner et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
A. Gronchi et al.
ANNALS OF ONCOLOGY (2021)
Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up
S. J. Strauss et al.
ANNALS OF ONCOLOGY (2021)
TRIM8 modulates the EWS/FLI oncoprotein to promote survival in Ewing sarcoma
Bo Kyung A. Seong et al.
CANCER CELL (2021)
Final overall survival in the phase 3 NETTER-1 study of lutetium-177-DOTATATE in patients with midgut neuroendocrine tumors.
Jonathan R. Strosberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survival
Nathaniel D. Anderson et al.
NATURE COMMUNICATIONS (2021)
Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers
Peter Horak et al.
CANCER DISCOVERY (2021)
Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART)
Michael J. Wagner et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Targeting cancer testis antigens in synovial sarcoma
Geoffrey Mitchell et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Early and Next-Generation KIT/PDGFRA Kinase Inhibitors and the Future of Treatment for Advanced Gastrointestinal Stromal Tumor
Sebastian Bauer et al.
FRONTIERS IN ONCOLOGY (2021)
European Reference Network for rare adult solid cancers, statement and integration to health care systems of member states: a position paper of the ERN EURACAN
J. -Y. Blay et al.
ESMO OPEN (2021)
The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives
Marta Sbaraglia et al.
PATHOLOGICA (2021)
EORTC SPECTA-AYA: A unique molecular profiling platform for adolescents and young adults with cancer in Europe
Teresa de Rojas et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials
David S. Hong et al.
LANCET ONCOLOGY (2020)
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials
Robert C. Doebele et al.
LANCET ONCOLOGY (2020)
B cells are associated with survival and immunotherapy response in sarcoma
Florent Petitprez et al.
NATURE (2020)
The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research
Corrie A. Painter et al.
NATURE MEDICINE (2020)
Tropomyosin receptor kinase inhibitors in the management of sarcomas
Christopher P. Wilding et al.
CURRENT OPINION IN ONCOLOGY (2020)
Guidelines for the Li-Fraumeni and heritable TP53-related cancer syndromes
Thierry Frebourg et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2020)
Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas The ANNOUNCE Randomized Clinical Trial
William D. Tap et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Sarcoma and the 100,000 Genomes Project: our experience and changes to practice
Sophie C. Prendergast et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2020)
Support systems to guide clinical decision-making in precision oncology: The Cancer Core Europe Molecular Tumor Board Portal
David Tamborero et al.
NATURE MEDICINE (2020)
Targeting CDK4 (cyclin-dependent kinase) amplification in liposarcoma: A comprehensive review
Tarek Assi et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
Angiosarcoma heterogeneity and potential therapeutic vulnerability to immune checkpoint blockade: insights from genomic sequencing
Amelie Boichard et al.
GENOME MEDICINE (2020)
Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial
Sylvie Bonvolot et al.
LANCET ONCOLOGY (2020)
First results of the EORTC-SPECTA/Arcagen study exploring the genomics of rare cancers in collaboration with the European reference network EURACAN
Marie Morfouace et al.
ESMO OPEN (2020)
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network
G. D. Demetri et al.
ANNALS OF ONCOLOGY (2020)
Rare cancers: A network for better care
Sergio Sandrucci et al.
EJSO (2019)
Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial
Breelyn A. Wilky et al.
LANCET ONCOLOGY (2019)
Defective homologous recombination DNA repair as therapeutic target in advanced chordoma
Stefan Groesche et al.
NATURE COMMUNICATIONS (2019)
The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs
D. L. van der Velden et al.
NATURE (2019)
Clinical Practice Guidance: Surveillance for phaeochromocytoma and paraganglioma in paediatric succinate dehydrogenase gene mutation carriers
Mei Yin Wong et al.
CLINICAL ENDOCRINOLOGY (2019)
Treatment challenges in and outside a network setting: Soft tissue sarcomas
Sandro Pasquali et al.
EJSO (2019)
A multinational, multi-tumour basket study in very rare cancer types: The European Organization for Research and Treatment of Cancer phase II 90101 'CREATE' trial
Julien Peron et al.
EUROPEAN JOURNAL OF CANCER (2019)
Diagnosis, Prognosis, and Treatment of Alveolar Soft-Part Sarcoma A Review
Luca Paoluzzi et al.
JAMA ONCOLOGY (2019)
A comprehensive review on MEN2B
Frederic Castinetti et al.
ENDOCRINE-RELATED CANCER (2018)
Contribution of de novo and mosaic TP53 mutations to Li-Fraumeni syndrome
Mariette Renaux-Petel et al.
JOURNAL OF MEDICAL GENETICS (2018)
Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors
Thomas A. Hope et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
BRCA2 Loss-of-Function and High Sensitivity to Cisplatin-Based Chemotherapy in a Patient With a Pleomorphic Soft Tissue Sarcoma: Effect of Genomic Medicine
Camille Tlemsani et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2018)
Revisiting tumor patterns and penetrance in germline TP53 mutation carriers: temporal phases of Li-Fraumeni syndrome
Amina Amadou et al.
CURRENT OPINION IN ONCOLOGY (2018)
Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial
Jonathan Strosberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Integrative genomic and transcriptomic analysis of leiomyosarcoma
Priya Chudasama et al.
NATURE COMMUNICATIONS (2018)
Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial
Patrick Schoffski et al.
LANCET RESPIRATORY MEDICINE (2018)
Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma The EORTC 62961-ESHO 95 Randomized Clinical Trial
Rolf D. Issels et al.
JAMA ONCOLOGY (2018)
Translational insights into gastrointestinal stromal tumor and current clinical advances
M. L. Hemming et al.
ANNALS OF ONCOLOGY (2018)
Cancer Molecular Screening and Therapeutics (MoST): a framework for multiple, parallel signal-seeking studies of targeted therapies for rare and neglected cancers
Subotheni Thavaneswaran et al.
MEDICAL JOURNAL OF AUSTRALIA (2018)
Characterization of the Neuroendocrine Tumor Immune Microenvironment
Annacarolina da Silva et al.
PANCREAS (2018)
Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility
Mitchell J. Machiela et al.
NATURE COMMUNICATIONS (2018)
Geographical Accessibility of the Sarcoma Referral Networks in France. Intermediate Results from the IGeAS Research Program
Yohan Fayet et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2018)
Clinical implications of germline mutations in breast cancer: TP53
Katherine Schon et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Genetic determinants of childhood and adult height associated with osteosarcoma risk
Chenan Zhang et al.
CANCER (2018)
Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 'CREATE'
P. Schoffski et al.
ANNALS OF ONCOLOGY (2018)
Improving treatment results with reference centres for rare cancers: where do we stand?
Isabelle Ray-Coquard et al.
EUROPEAN JOURNAL OF CANCER (2017)
Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F-DOPA
Murat Fani Bozkurt et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controls
Sibel Saya et al.
FAMILIAL CANCER (2017)
Precision oncology based on omics data: The NCT Heidelberg experience
Peter Horak et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial
Beatrice Seddon et al.
LANCET ONCOLOGY (2017)
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
Alessandro Gronchi et al.
LANCET ONCOLOGY (2017)
Soft tissue sarcomas in adolescents and young adults: a comparison with their paediatric and adult counterparts
Winette T. A. van der Graaf et al.
LANCET ONCOLOGY (2017)
Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial
William D. Tap et al.
LANCET ONCOLOGY (2017)
Whole-genome landscape of pancreatic neuroendocrine tumours
Aldo Scarpa et al.
NATURE (2017)
Germline and somatic genetics of osteosarcoma - connecting aetiology, biology and therapy
D. Matthew Gianferante et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
MAGEA4 expression in bone and soft tissue tumors: its utility as a target for immunotherapy and diagnostic marker combined with NY-ESO-1
Kunio Iura et al.
VIRCHOWS ARCHIV (2017)
Inherited TP53 Mutations and the Li-Fraumeni Syndrome
Tanya Guha et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas
Bryan Oronsky et al.
NEOPLASIA (2017)
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
Arvind Dasari et al.
JAMA ONCOLOGY (2017)
Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging A Meta-analysis
Mandy L. Ballinger et al.
JAMA ONCOLOGY (2017)
Neuroendocrine tumors and fibrosis: An unsolved mystery?
Faidon-Marios Laskaratos et al.
CANCER (2017)
Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'
P. Schoffski et al.
ANNALS OF ONCOLOGY (2017)
Increasing genomic instability during cancer therapy in a patient with Li-Fraumeni syndrome
Nadine Schuler et al.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2017)
Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas
Alexander J. Lazar et al.
CELL (2017)
Recommendations for Cancer Surveillance in Individuals with RASopathies and Other Rare Genetic Conditions with Increased Cancer Risk
Anita Villani et al.
CLINICAL CANCER RESEARCH (2017)
Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia
Jane E. Churpek et al.
CANCER (2016)
Predictive factors of response to mTOR inhibitors in neuroendocrine tumours
Maria Chiara Zatelli et al.
ENDOCRINE-RELATED CANCER (2016)
Risks of First and Subsequent Cancers Among TP53 Mutation Carriers in the National Cancer Institute Li-Fraumeni Syndrome Cohort
Phuong L. Mai et al.
CANCER (2016)
Genetics of neuroendocrine tumors
Joakim Crona et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study
Antoine Italiano et al.
LANCET ONCOLOGY (2016)
Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study
Anita Villani et al.
LANCET ONCOLOGY (2016)
Monogenic and polygenic determinants of sarcoma risk: an international genetic study
Mandy L. Ballinger et al.
LANCET ONCOLOGY (2016)
ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site
M. Pavel et al.
NEUROENDOCRINOLOGY (2016)
Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers
Gaelle Bougeard et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for 13 Cancer Types
Joshua N. Sampson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Palliative resection of the primary tumor in 442 metastasized neuroendocrine tumors of the pancreas: a population-based, propensity score-matched survival analysis
Felix J. Huettner et al.
LANGENBECKS ARCHIVES OF SURGERY (2015)
Germline Mutations in Predisposition Genes in Pediatric Cancer
Jinghui Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
Samuel A. Wells et al.
THYROID (2015)
Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency
Michal Kovac et al.
NATURE COMMUNICATIONS (2015)
Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for 13 Cancer Types
Joshua N. Sampson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas
Luis Jaime Castro-Vega et al.
HUMAN MOLECULAR GENETICS (2014)
Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)
Rajesh V. Thakker
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
Ian Judson et al.
LANCET ONCOLOGY (2014)
Recommendations for management of patients with neuroendocrine liver metastases
Andrea Frilling et al.
LANCET ONCOLOGY (2014)
Second and subsequent tumours among 1927 retinoblastoma patients diagnosed in Britain 1951-2004
A. MacCarthy et al.
BRITISH JOURNAL OF CANCER (2013)
Sarcomas in TP53 Germline Mutation Carriers A Review of the IARC TP53 Database
Simona Ognjanovic et al.
CANCER (2012)
RB1 mutations and second primary malignancies after hereditary retinoblastoma
Charlotte J. Dommering et al.
FAMILIAL CANCER (2012)
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Rajesh V. Thakker et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Life expectancy in hereditary cancer predisposing diseases: an observational study
Anna Wilding et al.
JOURNAL OF MEDICAL GENETICS (2012)
Involvement of the PI3K/Akt pathway in myxoid/round cell liposarcoma
Elizabeth G. Demicco et al.
MODERN PATHOLOGY (2012)
Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma
Sophie Postel-Vinay et al.
NATURE GENETICS (2012)
Long-Term Results of Surgery for Small Intestinal Neuroendocrine Tumors at a Tertiary Referral Center
Olov Norlen et al.
WORLD JOURNAL OF SURGERY (2012)
The Epidemiology of Sarcoma
Zachary Burningham et al.
CLINICAL SARCOMA RESEARCH (2012)
DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
Yuchen Jiao et al.
SCIENCE (2011)
Advances in sarcoma genomics and new therapeutic targets
Barry S. Taylor et al.
NATURE REVIEWS CANCER (2011)
Birth Incidence and Prevalence of Tumor-Prone Syndromes: Estimates From a UK Family Genetic Register Service
D. G. Evans et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2010)
Identification of the Receptor Tyrosine Kinase c-Met and Its Ligand, Hepatocyte Growth Factor, as Therapeutic Targets in Clear Cell Sarcoma
Ian J. Davis et al.
CANCER RESEARCH (2010)
DNA REPAIR ALTERATIONS IN CHILDREN WITH PEDIATRIC MALIGNANCIES: NOVEL OPPORTUNITIES TO IDENTIFY PATIENTS AT RISK FOR HIGH-GRADE TOXICITIES
Claudia E. Ruebe et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical Trials
Piotr Rutkowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
Jordi Barretina et al.
NATURE GENETICS (2010)
Crizotinib in ALK-Rearranged Inflammatory Myofibroblastic Tumor
James E. Butrynski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome
Steve Heymann et al.
RADIATION ONCOLOGY (2010)
CLINICAL RADIATION SENSITIVITY WITH DNA REPAIR DISORDERS: AN OVERVIEW
Julianne M. Pollard et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
Richard T. Kloos et al.
THYROID (2009)
A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma
Nabeel Pervaiz et al.
CANCER (2008)
Molecular basis of the Li-Fraumeni syndrome:: an update from the French LFS families
G. Bougeard et al.
JOURNAL OF MEDICAL GENETICS (2008)
Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?
P. Antunes et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas
Eva Hernando et al.
NATURE MEDICINE (2007)
Familial segmental neurofibromatosis
S Oguzkan et al.
JOURNAL OF CHILD NEUROLOGY (2004)
Share Paper
